Repro Med Systems (KRMD) Tops Q2 EPS by 4c

Repro Med Systems (NASDAQ: KRMD) reported Q2 EPS of $0.02, $0.04 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $12 million versus the consensus estimate of $11.62 million.

For earnings history and earnings-related data on Repro Med Systems (KRMD) click here.

You May Also Be Interested In

• Lutnick Says 'we Trust Anthropic' - Axios
• Increasing unusual option volume: GPRO JXN ALMS ALLY RSI PCG GTLB OLLI BAM
• Yatsen Holding (YSG) Reports Q2 Loss of $0.16